EPHX2, also known as soluble epoxide hydrolase (sEH), is a protein encoded by the EPHX2 gene in humans. This enzyme plays a crucial role in the metabolism of epoxyeicosatrienoic acids (EETs), which are signaling molecules found in the cytochrome P450-catalyzed epoxidation of arachidonic acid, a polyunsaturated omega-6 fatty acid.
EETs have various biological activities, including the regulation of blood pressure, inflammation, and angiogenesis, and they function as modulators of vascular tone and inflammatory responses. EPHX2 acts by converting these biologically active EETs into their corresponding dihydroxyeicosatrienoic acids (DHETs), which are generally less active. This hydrolytic conversion by EPHX2 serves as a key mechanism for the termination of EET signaling, thereby modulating their physiological effects. The enzyme EPHX2 is widely distributed in human tissues, with high expression levels in the liver, kidney, and vasculature, reflecting its systemic role in regulating EETs levels and thus influencing diverse physiological processes. Due to its involvement in the regulation of blood pressure and inflammatory pathways, EPHX2 has been a target of interest in pharmacological research, particularly concerning cardiovascular diseases and disorders related to inflammation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fibrates activate peroxisome proliferator-activated receptor alpha (PPARα), potentially increasing the expression of EPHX2 as part of lipid metabolism. | ||||||
Bis(2-ethylhexyl) phthalate | 117-81-7 | sc-254975 | 1 g | $57.00 | 2 | |
Phthalates, as endocrine disruptors, may cause an adaptive response leading to an increased expression of EPHX2 involved in detoxification processes. | ||||||
3-Methylcholanthrene | 56-49-5 | sc-252030 sc-252030A | 100 mg 250 mg | $388.00 $831.00 | 2 | |
3-Methylcholanthrene, a carcinogen, can induce the expression of EPHX2 as part of the body's defense mechanism against toxic metabolites. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
Clofibrate, a fibrate drug, can stimulate PPARα, leading to an increase in EPHX2 expression as part of the lipid regulation process. | ||||||
Lead(II) Acetate | 301-04-2 | sc-507473 | 5 g | $85.00 | ||
Lead(II) acetate exposure can elicit a cellular defense mechanism that includes the upregulation of EPHX2 for detoxification. | ||||||